Location: Home
  • search
  • go
  • Relate News
  • 11/2/2021China Deepens Healthcare Reform with Sanming Model and FYPs amid Suppl...
  • 11/2/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH E...
  • 11/2/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH Q...
  • 11/1/2021CANbridge Ties Up with UW School of Medicine for DMD Gene Therapy Rese...
  • 11/1/2021Junshi and Coherus Announce FDA Acceptance of Toripalimab BLA for Naso...
  • 11/1/2021Takeda Moves China HD/Asian Development Center to Shanghai FTZ as It E...
  • 11/1/2021Gannex Gains U.S. IND Approval of ASC43F, a First-in-Class Dual-Target...
  • 11/1/2021Sorrento/Lee's Submit Socazolimab NDA in China for Cervical Cancer
  • 11/1/2021HUTCHMED and AZ Initiate SAMETA Global P3 Trial of Savolitinib in Com...
  • 11/1/2021LianBio Raises $325 Million in IPO
  • 11/1/2021Shanghai's Low-Cost Supplementary Health Insurance Huhuibao Enrollment...
  • 11/1/2021Antengene Receives U.S. IND Approval for Phase 1 Trial of ATG-101 in S...
  • 10/30/2021Financial-related Company News in Brief
  • 10/30/2021Recent Executive Moves
  • 10/29/2021NMPA Announces Package Insert Revision of Zoledronic Acid Injection
  • 10/29/2021Pfizer Drones Light Up Night Sky in China's Remote Area with Health Ti...
  • 10/29/2021Seagen Stands by Newly Acquired HER2 Breast Cancer Drug Despite Compet...
  • 10/28/2021Updated Toby's Unofficial Chinese Orange Book User Guide
  • 10/28/2021NHC Releases the Draft Rules for Internet Diagnosis and Treatment Regu...
  • 10/28/2021KoBioLabs Announces Licensing Deal with SPH SINE for KBL697 and KBL693...
  • 10/28/2021Novo Nordisk's Xultophy Insulin (degludec/liraglutide) Wins Chinese Ap...
  • 10/28/2021HUYABIO Cleared P1 Trial of SHP2 Inhibitor for KRAS and EGFR Mutated T...
  • 10/27/2021Boehringer Ingelheim Submits Chinese NDA for First-in-class Spesolimab...
  • 10/27/2021Fosun to Take on Pfizer's Prevnar with Acquisition of Antejin Biotech
  • 10/27/2021Jemincare Group Accuses China Bohai Bank of Misusing Its CNY 2.8B Depo...
  • 10/26/2021PhIIC's China Generic Drug Bluebook 2021: Up 3.9% in 2019 but Down 16....
  • 10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
  • 10/26/2021I-Mab Enters Strategic Partnership with Sinopharm for Launch of its I...
  • 10/26/2021WHO Clears Chinese HPV Vaccine in Global Battle against Cervical Cance...
  • 10/26/2021SciNeuro and Mabylon to Co-develop Novel Therapeutics for Neurological...
  • Page:108/719 Total number of articles:21546: [First][<<] [106] [107] [108] [109] [110] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group